Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson
Stephen K
SK
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
McGinnis
Karen S
KS
Shapiro
Michael
M
Lehrer
Michael S
MS
Kim
Ellen J
EJ
Vittorio
Carmela C
CC
Junkins Hopkins
Jacqueline M
JM
Rook
Alain H
AH
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000077610:Bexarotene; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D017893:Photopheresis; D012751:Sezary Syndrome / Q000628:therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D016898:Interferon-alpha; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene